Medical International Technology Inc. (fka MDLH)

[Sirlarry78]

+70% today
good volume
let's rock it!

[garbageman]

does anyone know about the next Q report comin out,and also just wanted to say hi . NATE

[garbageman]

thank you guys for the feed back ;)

[Sirlarry78]

Well said!

With more news coming, we have a great week ahead of us.

[diablose94]

Well Garbage you bought at the top, I hate when that happens. Down here in the 20's you are probably pretty safe. We are shoring up support down here and my guess is this is where MDLH will make it's next move up from.

It seems to be holding the 50dayMA which is a good sign. If you can buy more shares down here and average down that might be a good idea too.

Next week I think it should start moving up again. Resistance at .28 and .35ish.

[Sirlarry78]

European group was short selling two weeks ago.
From what I heard, they did that on 500 000 shares and started a panic within the investor which drove the price down dramatically.

This is my interpretation based on the information that I have.

More news coming next week, so I heard!

[garbageman]

man whats going on ,just bought at .51 couple weeks ago never saw this comin, seemed like a company with alot of potential,any reason a stock would take a hard turn like that. any feed back would be welcomed.

[diablose94]

Just bought some shares. About 30k might buy another 15k soon if this thing looks like it's going to bounce off the 50day. MDLH seems to have a lot of potential!!

[Sirlarry78]

I'm under the impression somebody was short selling last week...

[alien42]

MDLH getting beat down on huge volume 2 days in a row, guess the Lebed pump is over...

[Sirlarry78]

Thanks!

[BMac22]

Ask and you shall receive!! : )

http://finance.yahoo.com/news/Major-research-report-on-MDLH-prnews-1349236681.html?x=0&.v=1

[Sirlarry78]

Why is that report not available on Google Finance, Yahoo Finace & most of the mainstream financial web platform???

[buyittradeit]

I like the way they broke it down. They could very well be right.

[BMac22]

1.15 Price target on MDLH from Cohen Independent Research!
http://whisperfromwallstreet.com/research/mdlhreport/

[buyittradeit]

That is actually a good sign. A 52 week high indicates a 52 week long trend. Resistance breaks it is time to scalp imo.

[Sirlarry78]

I'm concern it's not traidng over it's yearly high!
lol

[blackhawks]

Anyone concerned that it's trading near its yearly high?

[Sirlarry78]

Volume way up this morning on a 10% gainner.

[buyittradeit]

I agree the bigger the base the bigger the move. While it has appeared to have taking a break (for now) the news that they have gotten may have given this one the energy it needs for its next leg up?

Not sure.

Those that follow the Elliot Wave principle would more then likely say we are in between waves of a bullish move. One you have a bullish golden cross this indicates a bullish longer move.

In my opinion of course, this one could get interesting and is on my watch list.

[Sirlarry78]

News is out, tomorrow should be great! Maybe 1$

[chart guy]

Technical Analysis Video for MDLH

Looks like upwards momentum may be slowing down, but it may just be what we need. We could see a bull flag pattern develop, which normally are followed by another leg higher.

Check out the MDLH video chart here:
www.itsallbull.net/iabtv.php?string=MDLH_1&page=

[B7$4]

"News" Major milestone achieved by our joint venture in China

DENVER, CO, Feb. 10 /PRNewswire-FirstCall/ - Medical International Technology Inc. (MDLH.OB) www.mitneedlefree.com (MIT) is pleased to announce that its Chinese Joint Venture has achieved a major milestone and received the production certification to produce Med-Jet products in China.

MIT China's production facilities were the subject of a recent visit by the SFDA. These facilities were deemed suitable for medical device manufacturing, including the production of disposable accessories, by the SFDA and have therefore been granted a production certification.

Clinical trials of Med-Jet models MIT-MBX and MIT-H-III are set to begin in the near future. The obtainment of the production certification for human products together with the results from the clinical trials will represent an essential stepping-stone toward the ultimate goal of obtaining a licence to sell our Med-Jet injectors in China.

Projected Sales and Market Breakdown

On February 6th 2010 we announced in our Corporate Update that the company firmly believes it will grow revenues well past US$ 75,000,000 annually within the next three years. The following information will outline market expectations by category and timeframe:

Human applications:

Our initial target market for the first year is cosmetic Dermatology, Plastic surgery, and General Practitioner for single and mass injections, using Med-Jet models MIT MBX and MIT-H-III. The second year, in addition to the previous models, the introduction of model MIT-H-IV-1 and MIT-H-IV-5 will target private clinics and hospitals. During the third year, the injector for Diabetics, MIT P-I, and the Dental injector, MIT-H-VI, will be introduced and will drastically increase sales to achieve and exceed its forecasted US$ 55,000,000.

Animal applications:

Our initial target market for the first year is the pork, cattle, and poultry markets, using our existing and newly redesigned products for mass animal vaccination. The second year in addition to the previous models, MIT will introduce and market its day-old baby chicken injector, a highly-requested product by farmers around the world. During the third year, MIT will present 2 more new products expected to drastically increase sales to achieve and exceed its forecasted US$ 20,000,000.

Medical International Technology Inc. is proud to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) needle-free injection system.

About Medical International Technology, Inc. MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individuals and mass vaccinations.

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International Technology Inc. takes no obligation to update or correct forward-looking statements.

SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.

[penny stock champ]

BARCHART.COM OPINION INDICATES 100% STRONG BUY

http://barchart.com/opinions/MDLH

[Sirlarry78]

Hitting .56 this morning!

[narmana]

"My firm Lebed Biz LLC has been compensated by a third-party (Wall Street Grand, LLC) $20,000 cash for a one-month MDLH investor relations contract. Never invest into a stock we discuss unless you can afford to lose your entire investment. For our full disclaimer go to: www.lebed.biz/disclaimer.htm "

[Sirlarry78]

I figures at least .65 by the end of the week.
New PR comming Thursday, should be an other great week!

[TITAN]

I agree,$1.00 not that far at all.

[midtownmurphy]

Sure is, $1.00 not to far off. ) WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE JMHO

[TITAN]

MDLH Level 2 Very Thin.

[alien42]

MDLH, amazing month here, from .12 to .47

[jotuk6771]

Financial Condition and Results of Operations

During the fiscal year ending September 30, 2008 the Company experienced a net loss of $2,361,882, primarily comprised of selling, general and administrative expenses of $656,059 and research and development costs of $1,802,085. Included in research and development costs are expenses of $1,800,000 related to the Company's research and development contract with Idee International R&D, Inc., an affiliated entity. For the prior fiscal year 2007 the Company experienced a net loss of $898,376 where selling, general and administrative expenses totaled $830,363. And research and development costs were $134,294.

Net comprehensive loss, after adjustment for foreign currency translation, for fiscal year 2008 was $2,632,393.

For the twelve-months ended September 30, 2008 the Company experienced a decrease in sales of $9,813 compared to sales for the prior year. Gross profit for the twelve-months ended September 30, 2008 was $97,243 or approximately 30% of sales as compared to $216,652, or 64%. Costs of sales continue to be increased by the need to customize many of the items ordered to fit the particular needs of clients utilizing our products in new applications.

Liquidity and Capital Resources

During the fiscal year ending September 30, 2008 the Company's cash position decreased by $92,702. Net cash provided by operating activities was $521,257, resulting primarily from increases in related party payables and deferred income. Net cash used by financing activities was $332,014, resulting primarily from debt repayments of $282,318. Net cash used by investing activities was $4,648, resulting entirely from capital asset additions. The effect of exchange rates on cash during fiscal 2008 resulted in a decrease in cash values of $277,297.

The Company has reported a net liability position of $2,629,455 and has accumulated operation losses since inception of $9,333,413, which raises substantial doubt about the Company's ability to continue as a going concern. The continuation of the Company is dependent upon the continuing financial support of creditors and stockholders and upon obtaining the capital requirements for the continuing operations of the Company. Management believes actions planned and presently being taken provides the opportunity for the Company to continue as a going concern.

Medical International Technology, Inc. expects that revenues from existing and developing sales may not meet its liquidity requirements for the next 12-month period at its current level of operations. The company has been dependent on advances from related parties to maintain operations. There are no agreements, assurances or commitments to continue providing these advances. The company continues to rely on management to develop the business and work to develop sales. Management has and may continue to supplement cash flows from sales with additional equity and debt financing. Substantially, expanded operations are expected to require additional capital, either from a future offering of equity or the company pursuing other methods of financing, as appropriate.

[penny stock champ]

Medical International Technology (MIT) Inc. targeting a multi-billion dollar market with 3 new products


Medical International Technology (MIT) Inc. targeting a multi-billion dollar market with 3 new products

Feb. 8, 2010 (PR Newswire) -- Medical International Technology (MIT) Inc. targeting a multi-billion dollar market with 3 new products

DENVER, CO - Medical International Technology Inc. (MDLH.OB) www.mitneedlefree.com (MIT) is pleased to provide the following information about its new products for human diabetes, dentistry and poultry applications and their market potentials.

Diabetes

The International Diabetes Federation states that the diagnosis rate of diabetes has increased over the last two decades from 30 million to 246 million people with a disproportionate ratio coming from the United States, India, and China.

Medical International Technology Inc. is targeting this huge market with their newly developed Med-Jet model MIT-P-I within the next 8 to 10 month. "With our successful Chinese joint venture, MIT intends to introduce this new product in China first, thereafter we will have enough production capacity to sell all over the world", said Mr. Karim Menassa. The Med-Jet MIT-P-I is designed to be safe, precise, accurate, effective, easy to use and friendly to the environment.

Dentistry

According to the World Health Organization (WHO) statistics, last updated 26 October 2004, the number of dentists in the world was numbered in the millions. There are 234,104 registered Dentist in the USA, 18,861 in Canada, 50,920 in China and it is estimated that 400,000 will be needed by 2030. Statistics show there is an estimated average of 6 to 10 dentists for every 10,000 people in Europe.

It is estimated that 150,000 U.S. dentists could administer about 120 million doses of local Anaesthetics per year for the gums, for a total market of about $3.5 billion.

Medical International Technology Inc. is targeting this lucrative market with their Med-Jet model MIT-H-VI within the next 12 to 16 month. MIT intends to introduce this new product in North America first; other countries will follow shortly after. In the Dental Office, painful needle injections are enough to make even the most rational person skip dental visits. The Med-Jet MIT-H-VI will finally bring an end to traumatic dental visits.

Poultry Vaccinations

MIT's newly designed Agro-Jet model MIT-XII will help prevent the spread of deadly diseases by providing a needle-free alternative to the vaccination of billions of day-old baby chicks yearly. This high speed vaccinator will be able to inject thousands of birds per hour safely, precisely, accurately, effectively, with ease of use and friendly to the environment.

Medical International Technology Inc. is proud to continue providing a safe and effective means to help prevent the spread of deadly diseases to both humans and animals through the use of the Med-Jet(R) and Agro-Jet(R) needle-free injection system.

About Medical International Technology, Inc. MIT CANADA, with offices in Montreal, is a subsidiary of Denver, Colorado-based Medical International Technology, Inc. (MIT USA), which specializes in the development, production, marketing and sale of needle-free injectors both for humans and animals, for individuals and mass vaccinations.

The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties, including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development and acquisition of new product lines and services, government approval processes, the impact of competitive products or pricing a technological changes, the effect of economic conditions and other uncertainties, and the risk factors set forth from time to time in the Company's SEC reports, including but not limited to its annual report on Form 10-KSB; its quarterly reports on Forms 10-QSB; and any reports on Form 8-K. Medical International Technology Inc. takes no obligation to update or correct forward-looking statements.

SOURCE MEDICAL INTERNATIONAL TECHNOLOGIES INC.

Source: PR Newswire (February 8, 2010 - 9:30 AM EST)

News by QuoteMedia
www.quotemedia.com

[penny stock champ]

+1!

[penny stock champ]

1$ dollar doesn't seem too far away. Would be great for everyone getting in at these levels.

[penny stock champ]

Lets hope so. IMO this stock has the potential to reach those levels.

[Sirlarry78]

Hurry up, time to get onboard.
Ready to sky rock, great volume today!

[Sirlarry78]

5$, I wish....let's not dream in color!

[Sirlarry78]

Soon this will be at a 1$, expecting more news this week!

[TITAN]

I agree,and IMO share price should be at $5.00 if not more.

[TITAN]

$110,267 traded so far in MDLH $$$$$

[midtownmurphy]

Next year at this time MIT will be a household name in the U.S.

[midtownmurphy]

It's off and running. WOWEEEEEEEEEEEEEEEEEEEEEEEEEEEE

[TITAN]

MDLH is a one of a kind company that is the LEADER in needle-free injections! Imagine a world without needles. If you know a diabetic or realized how many diseases are spread from the use of needles I think you would agree that if we could eliminate the use for needles then the world would be a lot safer.

[TITAN]

MDLH CHART

[TITAN]

MDLH CHART

[TITAN]

What do you say MDLH get's the love she needs this week? Im thinking good volume this week.

[midtownmurphy]

LOL Larry .40 today.WEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEEE

[Sirlarry78]

just hit .29, I love it!

[Sirlarry78]

Hope you did more then simply called it
and bought some at .07.
Good run so far...go mdlh!